Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1987-11-13
1991-08-20
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
424 851, 424 854, 4352401, 4352402, 43524021, A61K 3900
Patent
active
050412892
ABSTRACT:
A method is disclosed for removing residual tumor cells from a patient with a neoplastic disorder by treating in vitro cell preparation with lymphokine activated cytotoxic cells.
REFERENCES:
patent: 4604377 (1986-08-01), Fernandes et al.
patent: 4690915 (1987-09-01), Rosenberg
patent: 4714680 (1987-12-01), Civin
Sarh, Suina 238, 1987, pp. 1374-1379.
Suda et al., Blood 67(4) 1986, pp. 1002-1006.
Donahue et al., Blood 66(6) 1985, pp. 1479-1481.
Immunobiology of Natural Killer Cells, vol. I, 1986, ed. Lotzova et al., pp. 30-50, 90-102.
Shaw et al., Cell. Immunol, vol, 91, 1985, pp. 193-200.
Artaldo et al., J. Exp. Med. 164, ,1986, pp. 1193-1205.
Van de Griend et al., J Immunology vol. 136, 1986, pp. 1700-1707.
Lavier et al., J Immunol vol. 134, 1985, pp. 794-801.
Hogan et al., J Immunal vol. 135, 1985, pp. 1731-1738.
Sci. American, Medicine, vol. 1, 5:VIII (1987).
Civin et al., Exp. Hematol., 15:10 (1987).
Mageed et al., Cancer, 60:2913 (Dec. 15, 1987).
Tong et al., Blood, 70:1482 (Nov. 1987).
Ottow et al., Cancer, 60:1465(1987).
Hao et al., J. Immunol., 140:4042 (1988).
Lanier Lewis L.
Nagler Arnon
Phillips Joseph H.
Becton Dickinson and Company
Draper Garnette D.
Hallenbeck Robert M.
LandOfFree
Method of purging residual tumor cells in vitro with lymphokine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of purging residual tumor cells in vitro with lymphokine , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of purging residual tumor cells in vitro with lymphokine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1006903